UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2022		82,653,781
Beginning balances at Dec. 31, 2022	$ (132,711)	$ 9	$ 513,614	$ 6	$ (646,340)
Increase (decrease) in stockholders' equity [Roll Forward]
Stock-based compensation	3,363		3,363
Release of restricted stock units (in shares)		915,206
Cancellation of shares used to settle payroll tax withholding (in shares)		(246,717)
Cancellation of shares used to settle payroll tax withholding	(345)		(345)
Issuance of common stock (in shares)		11,900,400
Issuance of common stock	25,695	$ 1	25,694
Foreign currency translation adjustment, net of tax	1			1
Net loss	(71,600)				(71,600)
Ending balances (in shares) at Mar. 31, 2023		95,222,670
Ending balances at Mar. 31, 2023	$ (175,597)	$ 10	542,326	7	(717,940)
Beginning balances (in shares) at Dec. 31, 2023	199,133,827	199,133,827
Beginning balances at Dec. 31, 2023	$ (110,800)	$ 21	765,018	7	(875,846)
Increase (decrease) in stockholders' equity [Roll Forward]
Stock-based compensation	2,941		2,941
Release of restricted stock units (in shares)		657,605
Cancellation of shares used to settle payroll tax withholding (in shares)		(251,967)
Cancellation of shares used to settle payroll tax withholding	(308)		(308)
Issuance of common stock (in shares)		7,239,982
Issuance of common stock	7,207	$ 1	7,206
Foreign currency translation adjustment, net of tax	(5)			(5)
Net loss	$ (46,708)				(46,708)
Ending balances (in shares) at Mar. 31, 2024	206,779,447	206,779,447
Ending balances at Mar. 31, 2024	$ (147,673)	$ 22	$ 774,857	$ 2	$ (922,554)